RxSight, Inc. (RXST) research
RxSight, Inc.- Sector
- Health Care
- Last price
- $4.85
- As of
RxSight, Inc. (RXST): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-05.
As of . Source: SEC EDGAR filings for RXST. Method and limitations.
Share the RXST intelligence card
See RXST live in the terminal
Track RXST's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live RXST terminal, freeActive signals for RXST
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +133% to RXST (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +107% to RXST (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +4700% to RXST (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +133% to RXST (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +107% to RXST (2026Q2)
FREE, NO ACCOUNT
Every signal on RXST, as it fires
You are seeing 5 of 18 signals recorded on RXST since 2026-06-05.
The five above all landed on 2026-09-06. The other 13 were recorded on 5 other days. 12 of the 18 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in RXST (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 78349D107 · 2026Q2 | $14.6M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 78349D107 · 2026Q2 | $9.6M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 78349D107 · 2026Q2 | $5.5M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 78349D107 · 2026Q2 | $3.8M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 78349D107 · 2026Q2 | $3.4M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 78349D107 · 2026Q2 | $678K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, RXST
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
RXST against its peers
RXST's operating margin of -35.8% ranks in the 17th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | RXST | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 134M USD | 344M USD | 13 | 25 |
| Gross margin | 76.6% | 58.4% | 82 | 13 |
| Operating margin | -35.8% | -8.0% | 17 | 25 |
| Net margin | -29.0% | -8.3% | 29 | 25 |
| Return on equity | -14.1% | -14.5% | 52 | 23 |
| P / E | n/a | 47.1x | n/a | 5 |
Peers (25): INGN, SLP, EVH, CCRN, SGHT, DH, CTEV, CERS, FLGT, ANGO, ACH, EHAB, AHCO, VREX, HSTM, TALK, BVS, STAA, CSTL, PRCT, IRMD, TDOC, GDRX, TNDM, USPH. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (RXST: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more RXST signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to RXSTand get the insider, 13F, options, and confluence read in one view.